These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17410456)

  • 1. Randomised, Double-blind, Placebo-controlled Trial of CCR9-targeted Leukapheresis Treatment of Ulcerative Colitis Patients.
    Eberhardson M; Karlén P; Linton L; Jones P; Lindberg A; Kostalla MJ; Lindh E; Odén A; Glise H; Winqvist O
    J Crohns Colitis; 2017 May; 11(5):534-542. PubMed ID: 28453759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel Disease.
    Katz S
    Gastroenterol Hepatol (N Y); 2006 Dec; 2(12):906-913. PubMed ID: 28331481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis.
    Kiss S; Németh D; Hegyi P; Földi M; Szakács Z; Erőss B; Tinusz B; Hegyi PJ; Sarlós P; Alizadeh H
    BMJ Open; 2021 May; 11(5):e042374. PubMed ID: 34011580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.
    Iizuka M; Etou T; Kumagai M; Matsuoka A; Numata Y; Sagara S
    Intern Med; 2017 Oct; 56(20):2705-2710. PubMed ID: 28924114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.
    De Cassan C; Savarino E; Marson P; Tison T; Hatem G; Sturniolo GC; D'Incà R
    World J Gastroenterol; 2014 Dec; 20(45):17155-62. PubMed ID: 25493030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging.
    Törüner M; Toprak SK; Mızrak K; Yıldırım Y; Bay M; Ayyıldız E; Ilhan O
    Turk J Haematol; 2013 Jun; 30(2):219-20. PubMed ID: 24385792
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid-sparing strategies in the management of ulcerative colitis: efficacy of leukocytapheresis.
    Shiraki M; Yamamoto T
    World J Gastroenterol; 2012 Nov; 18(41):5833-8. PubMed ID: 23139598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis.
    Zhu M; Xu X; Nie F; Tong J; Xiao S; Ran Z
    Int J Colorectal Dis; 2011 Aug; 26(8):999-1007. PubMed ID: 21476027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
    Naganuma M; Fujii T; Watanabe M
    J Gastroenterol; 2011 Feb; 46(2):129-37. PubMed ID: 21132334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte apheresis in the management of ulcerative colitis.
    Helmy A; Abdulla M; Kagevi I; Al Kahtani K
    Saudi J Gastroenterol; 2009; 15(4):283-7. PubMed ID: 19794281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis.
    Habermalz B; Sauerland S
    Dig Dis Sci; 2010 May; 55(5):1421-8. PubMed ID: 19517236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.
    Umehara Y; Kudo M; Kawasaki M
    World J Gastroenterol; 2008 Sep; 14(34):5316-21. PubMed ID: 18785285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis.
    Waitz G; Petermann S; Liebe S; Emmrich J; Ramlow W
    Dig Dis Sci; 2008 Sep; 53(9):2507-15. PubMed ID: 18253828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
    Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
    Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
    Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
    Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
    Yokoyama Y; Matsuoka K; Kobayashi T; Sawada K; Fujiyoshi T; Ando T; Ohnishi Y; Ishida T; Oka M; Yamada M; Nakamura T; Ino T; Numata T; Aoki H; Sakou J; Kusada M; Maekawa T; Hibi T
    J Crohns Colitis; 2014 Sep; 8(9):981-91. PubMed ID: 24556083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
    Tsujikawa T; Andoh A; Ogaẃa A; Sonoda A; Yagi Y; Hata K; Sasaki M; Saito Y; Fujiyama Y
    Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytapheresis for the treatment of IBD.
    Sigurbjörnsson FT; Bjarnason I
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):509-16. PubMed ID: 18665138
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.